These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 6944647)
21. Effect of nifedipine on urinary calcium and oxalate excretion in renal stone formers. Baggio B; Gambaro G; Marchini F; Cicerello E; Borsatti A Nephron; 1986; 43(3):234-5. PubMed ID: 3724934 [No Abstract] [Full Text] [Related]
22. [Urine analyses for workup of kidney stone disease--interpretation and therapeutic consequences]. Pasch A Ther Umsch; 2006 Sep; 63(9):569-74. PubMed ID: 17048170 [TBL] [Abstract][Full Text] [Related]
23. Crystallization properties in urine from calcium oxalate stone formers. Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098 [TBL] [Abstract][Full Text] [Related]
24. [Determination of calcium, oxalate and inhibitory activity of the urine in patients with calcium nephrolithiasis]. Han KH; Cao LC; Ying YL Zhonghua Wai Ke Za Zhi; 1986 Mar; 24(3):173-5, 190. PubMed ID: 3757655 [No Abstract] [Full Text] [Related]
25. Body size and 24-hour urine composition. Taylor EN; Curhan GC Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145 [TBL] [Abstract][Full Text] [Related]
30. Determinants of supersaturation levels and crystallization rates of calcium oxalate from urines of normal humans and stone formers: effects of nondialyzable materials. Gill WB; Roma MJ J Surg Res; 1976 Jul; 21(1):45-9. PubMed ID: 933515 [No Abstract] [Full Text] [Related]
31. The significance of crystalluria in renal stone formation. Robertson WG; Peacock M; Nordin BE Br J Surg; 1969 May; 56(5):388-9. PubMed ID: 5781083 [No Abstract] [Full Text] [Related]
32. Activity products in stone-forming and non-stone-forming urine. Robertson WG; Peacock M; Nordin BE Clin Sci; 1968 Jun; 34(3):579-94. PubMed ID: 5666884 [No Abstract] [Full Text] [Related]
33. Analysis of calcium, oxalate, and citrate interaction in idiopathic calcium urolithiasis in children. Milosević D; Batinić D; Konjevoda P; Blau N; Stambuk N; Nizić L; Vrljicak K; Batinić D J Chem Inf Comput Sci; 2003; 43(6):1844-7. PubMed ID: 14632431 [TBL] [Abstract][Full Text] [Related]
34. Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis. Cohanim M; Yendt ER Invest Urol; 1980 Sep; 18(2):170-3. PubMed ID: 7410033 [TBL] [Abstract][Full Text] [Related]
35. Calcium crystalluria in recurrent renal-stone formers. Robertson WG; Peacock M; Nordin BE Lancet; 1969 Jul; 2(7610):21-4. PubMed ID: 4182793 [No Abstract] [Full Text] [Related]
36. Possible role of carbohydrate-induced calciuria in calcium oxalate kidney-stone formation. Lemann J; Piering WF; Lennon EJ N Engl J Med; 1969 Jan; 280(5):232-7. PubMed ID: 5818178 [No Abstract] [Full Text] [Related]
37. Effects of low calcium diet on urinary calcium and oxalate excretion in patients with idiopathic calcium nephrolithiasis. Colussi G; Antonacci A; Surian M; Pontoriero G; Rombolà G; De Ferrari ME; Cosci P; Malberti F; Minetti L Contrib Nephrol; 1984; 37():22-6. PubMed ID: 6713874 [No Abstract] [Full Text] [Related]
38. Relationship between the severity of renal stone disease and urine composition. Tiselius HG Eur Urol; 1979; 5(5):323-7. PubMed ID: 446508 [TBL] [Abstract][Full Text] [Related]
39. Bone mass loss in calcium stone disease: focus on hypercalciuria and metabolic factors. Caudarella R; Vescini F; Buffa A; Sinicropi G; Rizzoli E; La Manna G; Stefoni S J Nephrol; 2003; 16(2):260-6. PubMed ID: 12768074 [TBL] [Abstract][Full Text] [Related]
40. Comparative study of the influence of 3 types of mineral water in patients with idiopathic calcium lithiasis. Caudarella R; Rizzoli E; Buffa A; Bottura A; Stefoni S J Urol; 1998 Mar; 159(3):658-63. PubMed ID: 9474120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]